All Pharma News
Bio-Path Presents Prexigebersen AML Combo Data At EHA 2024

Bio-Path Presents Prexigebersen AML Combo Data At EHA 2024
GLOBENEWSWIRE
14 Jun 2024
Share Share
Bio-Path Holdings Announces Closing of $4.0 Million Private Placement

Bio-Path Holdings Announces Closing of $4.0 Million Private Placement
GLOBENEWSWIRE
05 Jun 2024
Share Share
Bio-Path: $4M Private Placement Priced At Nasdaq Market

Bio-Path: $4M Private Placement Priced At Nasdaq Market
GLOBENEWSWIRE
04 Jun 2024
Share Share
Bio-Path`s Prexigebersen AML Combo Data At ASCO 2024

Bio-Path`s Prexigebersen AML Combo Data At ASCO 2024
GLOBENEWSWIRE
03 Jun 2024
Share Share
Bio-Path Eha 2024 Data: To Be Presented At European Congress

Bio-Path Eha 2024 Data: To Be Presented At European Congress
GLOBENEWSWIRE
24 May 2024
Share Share
Bio-Path Asco 2024 Data: To Be Presented At Annual Meeting

Bio-Path Asco 2024 Data: To Be Presented At Annual Meeting
GLOBENEWSWIRE
23 May 2024
Share Share
Bio-Path Holdings Reports First Quarter 2024 Financial Results

Bio-Path Holdings Reports First Quarter 2024 Financial Results
GLOBENEWSWIRE
15 May 2024
Share Share
Bio-Path Q1 2024 Results On May 15

Bio-Path Q1 2024 Results On May 15
GLOBENEWSWIRE
08 May 2024
Share Share
Bio-Path Closes $1.2M Registered Direct Offering At Market

Bio-Path Closes $1.2M Registered Direct Offering At Market
GLOBENEWSWIRE
19 Apr 2024
Share Share
Bio-Path Completes Higher Dose AML Trial Cohort For BP1002

Bio-Path Completes Higher Dose AML Trial Cohort For BP1002
GLOBENEWSWIRE
18 Apr 2024
Share Share